Scancell Holdings plc (LON:SCLP - Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 10.75 ($0.14) and traded as low as GBX 10 ($0.13). Scancell shares last traded at GBX 11.65 ($0.15), with a volume of 2,178,450 shares changing hands.
Scancell Trading Up 11.0 %
The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The business's 50-day moving average is GBX 8.67 and its two-hundred day moving average is GBX 10.75. The firm has a market cap of £120.66 million, a P/E ratio of -17.86 and a beta of 0.35.
Scancell (LON:SCLP - Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. As a group, analysts expect that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.
Scancell Company Profile
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
